PATENT CLAIM ANALYSIS

Application Number: 15866744
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "180000"]

Abstract:
The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which contains difluprednate as an active ingredient. The eye drop can afford effects such as improvement of visual acuity and decreased foveal retinal thickness in macular edema.

Claim (Index 46):
The method according to  claim 41 , wherein the emulsion eye drop further comprises castor oil, polysorbate 80, concentrated glycerin, sodium acetate, boric acid, sodium edetate and sorbic acid.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14661295', '13940370', '15471506', '11695527', '14972560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7793696491004484
- 35 USC 102 Novelty (BERT): 0.6422450486079028
- Combined Prediction Score: 0.7656571890511937
- Mean Citation Score: 323.74317600000006
- Max Citation Score: 652.79486
- Similarity Product: 556.5812102219152

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test